[HTML][HTML] Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt, L Medzikovic… - Respiratory …, 2020 - Springer
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

[HTML][HTML] Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - ncbi.nlm.nih.gov
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

[PDF][PDF] Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt, L Medzikovic… - group, 2020 - researchgate.net
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent comorbidity. The high prevalence of PH in PF patients is very …

[PDF][PDF] Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt, L Medzikovic… - group, 2020 - scholar.archive.org
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent comorbidity. The high prevalence of PH in PF patients is very …

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Pulmonary hypertension (PH) developing
secondarily in pulmonary fibrosis (PF) patients (PF-PH) is a frequent co-morbidity. The high …

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - escholarship.org
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

[HTML][HTML] Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong… - Respiratory …, 2020 - respiratory-research.biomedcentral …
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights.

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - europepmc.org
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - search.proquest.com
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …

Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights

G Ruffenach, J Hong, M Vaillancourt… - Respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Pulmonary hypertension (PH) developing secondarily in pulmonary fibrosis (PF) patients
(PF-PH) is a frequent co-morbidity. The high prevalence of PH in PF patients is very …